Loading clinical trials...
Loading clinical trials...
This study will determine if administration of an suspension of calfactant, a lung surfactant, intratracheally in patients with Direct Acute Respiratory Distress Syndrome within 48 hours of requiring ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Pneuma Pharmaceuticals Incorporated
NCT02273687 · Respiratory Distress Syndrome, Adult
NCT01743105 · Respiratory Distress Syndrome, Adult
NCT05496868 · Acute Respiratory Distress Syndrome, Adult
NCT05081895 · Respiratory Failure, Respiratory Distress Syndrome, Adult, and more
NCT04139733 · Respiratory Distress Syndrome, Adult
University of Florida
Gainesville, Florida
Florida Hospital and Florida Children's Hospital
Orlando, Florida
Northwestern University-Chicago
Chicago, Illinois
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions